The most common use case, providing quick estimations of drug exposure (AUC), half-life, and clearance.
In the world of pharmacokinetics (PK), pharmacodynamics (PD), and complex statistical modeling, "Nonlin" is more than just a name—it is a standard. Whether you are a researcher in a biotech startup or a scientist at a global pharmaceutical firm, understanding the evolution and utility of is essential for moving drugs from the lab to the clinic.
Originally developed in the 1960s (notably by CM Metzler), NONLIN was a mainframe-based program. It allowed scientists to estimate parameters for nonlinear models, a task that was previously incredibly labor-intensive.